Get App
Download App Scanner
Scan to Download
Advertisement

Small Caps, Mid Caps Offer 'Lucrative Opportunity' Amid Ongoing Correction, Says Nippon Fund Manager

Fund manager Rahul Veera sees the recent market correction as a prime buying opportunity. He favours small private banks and pharma exporters over large caps.

Small Caps, Mid Caps Offer 'Lucrative Opportunity' Amid Ongoing Correction, Says Nippon Fund Manager
Photo: NDTV Profit
  • Rahul Veera sees market correction as a chance for bottom-up stock picking in broader markets
  • Energy crisis pressures manufacturing profits, but market has priced in war impact on India
  • Preference given to small private banks due to cheaper valuations and no major NPA cycle
Did our AI summary help?
Let us know.

Despite the ongoing turmoil in the Middle East that has put immense pressure on energy prices and has led to FII outflows, Rahul Veera, a fund manager at Nippon India AIF, believes the correction is creating a lucrative opportunity for bottom-up stock picking, particularly within the broader market.

Speaking to NDTV Profit, Veera pointed out that while the energy crisis continues to put pressure on manufacturing profits, the market has priced in these disruptions.

 "In terms of valuation correction, it has not happened, but in terms of market correction or time correction, the market has already priced in the current till-date impact of the war on Indian markets," Veera said.

Veera particularly highlighted a shift toward the services sector and high-conviction plays in banking and pharmaceuticals. Drawing parallels to the 2011-2019 cycle, he identified banking as a "clear-cut winner" due to cheaper valuations and the absence of a major NPA cycle.

"It's going to be small private banks, that is going to be our first preference. Since the NPA cycle is not there, the comfort is much higher on these smaller names," he added.

Addressing the recent breach of the 95-per-dollar mark for the rupee, Veera added that currency depreciation would act as a tailwind for exporters.

"Pharma and pharma exporters, again, small-cap and large-cap, both sides, there are lucrative opportunities in the pharma space for sure," he stated. He pointed out that logistical issues have driven up domestic API prices, benefiting smaller players.

While remaining cautious on large-cap retail and energy, Veera emphasised a disciplined, valuation-driven approach.

"Lot of companies are available in a single-digit PE as of now if we have a two-to-three-year kind of a framework. So we continue to allocate incremental capital towards small caps and mid caps from here on," he concluded.

ALSO READ: Iran War: India Emerges As A Key Outperformer On Fuel Prices But The Kitchen Is Burning

Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search
Add NDTV Profit As Google Preferred Source